Status:
UNKNOWN
Automated Quantification of Radiologic Pulmonary Alteration During Acute Respiratory Failure: Application to the COVID-19 Pandemic
Lead Sponsor:
University Hospital, Strasbourg, France
Collaborating Sponsors:
REGION GRAND EST
E-MEDIA
Conditions:
SARS-CoV-2 Infections
Respiratory Failure With Hypoxia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Automated quantification of the pulmonary volume impaired during acute respiratory failure could be helpful to assess patient severity during COVID-19 infection or perioperative medicine, for example....
Eligibility Criteria
Inclusion
- Subject admitted to a care unit of the University Hospitals of Strasbourg or the University Hospital of Nancy and presenting a suspicion of SARS-CoV-2 infection or postoperative hypoxemic respiratory failure
- Able to understand the objectives and risks of the research and to give dated and signed informed consent.
- Subjects may also be included in emergency or immediate life-threatening situations.
- Subject with insurance covering
Exclusion
- Pregnant woman (pregnancy confirmed by a urine or blood test)
- Subject usually on home oxygen therapy
- Subject under court protection
- Subject under guardianship or curatorship
Key Trial Info
Start Date :
June 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05278390
Start Date
June 13 2022
End Date
June 1 2025
Last Update
June 30 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'anesthésie réanimation-CHU de Nancy
Nancy, France, 54500
2
Service d'Anesthésie-Réanimation - CHU Strasbourg
Strasbourg, France, 67098